Williams Jones & Associates’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $25K | Sell |
140,000
-10,000
| -7% | -$1.79K | ﹤0.01% | 391 |
|
|
2019
Q1 | $35K | Hold |
150,000
| – | – | ﹤0.01% | 406 |
|
|
2018
Q4 | $23K | Hold |
150,000
| – | – | ﹤0.01% | 389 |
|
|
2018
Q3 | $27K | Hold |
150,000
| – | – | ﹤0.01% | 441 |
|
|
2018
Q2 | $30K | Hold |
150,000
| – | – | ﹤0.01% | 438 |
|
|
2018
Q1 | $33K | Hold |
150,000
| – | – | ﹤0.01% | 441 |
|
|
2017
Q4 | $26K | Hold |
150,000
| – | – | ﹤0.01% | 435 |
|
|
2017
Q3 | $50K | Buy |
150,000
+40,000
| +36% | +$13.3K | ﹤0.01% | 425 |
|
|
2017
Q2 | $30K | Hold |
110,000
| – | – | ﹤0.01% | 409 |
|
|
2017
Q1 | $32K | Hold |
110,000
| – | – | ﹤0.01% | 402 |
|
|
2016
Q4 | $35K | Hold |
110,000
| – | – | ﹤0.01% | 373 |
|
|
2016
Q3 | $41K | Hold |
110,000
| – | – | ﹤0.01% | 393 |
|
|
2016
Q2 | $51K | Buy |
+110,000
| New | +$51K | ﹤0.01% | 380 |
|